From Risk Aversion to Real-World Impact: How Medtech Firms Can Harness AI

 
• By Elizabeth Orr
  
Medtech firms need to overcome the ‘risk-aversive shrug’ on AI adoption. (Shutterstock)

More from AI

More from Digital Technologies